Type 2 Diabetes
Conditions
Keywords
imbalanced diabetic patients, HbA1c, peers
Brief summary
In the IMPACT project, the investigators want to improve adherence and commitment to treatment.
Detailed description
In this study the investigators use 3 interventions in diabetic patients and one control, to find what is the best intervention to improve adherence to healthy life style and medication therapy. the 3 intervention as followed: 1) meetings and follow-up by the medical team; 2) meetings and follow-up by trained peers; 3) system for sending SMS, operate according to algorithm.
Interventions
BEHAVIORALmedical team
Lowering HbA1c by behavioral changes in meetings with the medical team.
BEHAVIORALpeers group
Lowering HbA1c by behavioral changes in meetings with the peers group.
BEHAVIORALSMS notification
Lowering HbA1c by behavioral changes in meetings with the SMS notification
Sponsors
Clalit Health Services
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
1. type 2 diabetes 2. age 30-70 3. Oral medication or insulin 4. According to the HbA1c test result, 0.5% above the target for the patient's personal balance and below the 10%, the most recent, but in any event not more than six months prior to the study patient recruitment 5. BMI\<35 6. Patients speak and read Hebrew 7. owners of a mobile phone that can receive text messages (SMS messages/ notifications) and have the ability to use the application (relevant for the SMS notification arm)
Exclusion criteria
1. Active malignant disease 2. creatinine levels above 2 3. Getting medicines that elevate sugar levels as steroids, chemotherapy 4. Three months after Myocardial Infraction (myocardial ischemia), surgical intervention, cardiac event 5. Patients who are planning major surgery 6. Patients who are planning a residential zone change 7. Patients with acute complications of diabetes under active treatment (such as limb amputation) 8. Patients diagnosed with unbalanced mental disorders 9. patients who can not sign the form on their own informed consent 10. patients suffering from dementia 11. Patients who are not mobile (dependent on the therapist)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diabetes Control as Expressed by the Change in HbA1c % | 0, 6, 12 & 18 months | Participants will undergo HbA1c periodical lab test, the data needed for the trial will be extracted from electronic medical record |
Countries
Israel
Contacts
Primary ContactMargalit Goldfracht, prof.
Backup ContactNiky Liberman, DR
Outcome results
None listed